Literature DB >> 1404298

X inactivation patterns in females with Alport's syndrome: a means of selecting against a deleterious gene?

D Vetrie1, F Flinter, M Bobrow, A Harris.   

Abstract

The patterns of X chromosome inactivation in 43 females from families segregating classic Alport's syndrome (AS) (X linked hereditary nephritis with deafness) have been analysed. AS carrier females have a most variable clinical course. The aim of the study was to establish whether there was any correlation between the X inactivation pattern of a carrier female and the severity of her disease. No correlation was found in DNA derived from peripheral blood lymphocytes. However, it remains possible that differential patterns of X inactivation may occur in the tissues affected by AS, namely the basement membrane of the kidney, eye, and ear.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1404298      PMCID: PMC1016101          DOI: 10.1136/jmg.29.9.663

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome.

Authors:  J Zhou; D F Barker; S L Hostikka; M C Gregory; C L Atkin; K Tryggvason
Journal:  Genomics       Date:  1991-01       Impact factor: 5.736

2.  Identification of mutations in the COL4A5 collagen gene in Alport syndrome.

Authors:  D F Barker; S L Hostikka; J Zhou; L T Chow; A R Oliphant; S C Gerken; M C Gregory; M H Skolnick; C L Atkin; K Tryggvason
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

3.  Localization of the gene for classic Alport syndrome.

Authors:  F A Flinter; S Abbs; M Bobrow
Journal:  Genomics       Date:  1989-04       Impact factor: 5.736

4.  Linkage studies in X-linked Alport's syndrome.

Authors:  S Szpiro-Tapia; G Bobrie; M Guilloud-Bataille; S Heuertz; C Julier; J Frézal; J P Grünfeld; M C Hors-Cayla
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

Review 5.  Genetics of classic Alport's syndrome.

Authors:  F A Flinter; J S Cameron; C Chantler; I Houston; M Bobrow
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

6.  Localization of the gene for X-linked Alport's syndrome.

Authors:  H Brunner; C Schröder; C van Bennekom; E Lambermon; J Tuerlings; D Menzel; H Olbing; L Monnens; B Wieringa; H H Ropers
Journal:  Kidney Int       Date:  1988-10       Impact factor: 10.612

7.  Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; A P Feinberg
Journal:  Science       Date:  1985-02-08       Impact factor: 47.728

8.  Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase.

Authors:  D J Jolly; A C Esty; H U Bernard; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Major rearrangements in the alpha 5(IV) collagen gene in three patients with Alport syndrome.

Authors:  E Boye; D Vetrie; F Flinter; B Buckle; T Pihlajaniemi; E R Hamalainen; J C Myers; M Bobrow; A Harris
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

10.  Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation.

Authors:  S F Wolf; D J Jolly; K D Lunnen; T Friedmann; B R Migeon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

View more
  9 in total

1.  X inactivation patterns in female monozygotic twins and their families.

Authors:  E Watkiss; T Webb; G Rysiecki; N Girdler; E Hewett; S Bundey
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

2.  Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.

Authors:  C Guo; B Van Damme; Y Vanrenterghem; K Devriendt; J J Cassiman; P Marynen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

3.  X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome.

Authors:  Michelle N Rheault; Stefan M Kren; Linda A Hartich; Melanie Wall; William Thomas; Hector A Mesa; Philip Avner; George E Lees; Clifford E Kashtan; Yoav Segal
Journal:  Nephrol Dial Transplant       Date:  2009-10-23       Impact factor: 5.992

Review 4.  Population-based studies reveal an additive role of type IV collagen variants in hematuria and albuminuria.

Authors:  Moumita Barua; Andrew D Paterson
Journal:  Pediatr Nephrol       Date:  2021-02-26       Impact factor: 3.714

Review 5.  Women and Alport syndrome.

Authors:  Michelle N Rheault
Journal:  Pediatr Nephrol       Date:  2011-03-05       Impact factor: 3.714

6.  X-Linked Alport Syndrome in Women: Genotype and Clinical Course in 24 Cases.

Authors:  Antonio Mastrangelo; Marisa Giani; Elena Groppali; Pierangela Castorina; Giulia Soldà; Michela Robusto; Chiara Fallerini; Mirella Bruttini; Alessandra Renieri; Giovanni Montini
Journal:  Front Med (Lausanne)       Date:  2020-11-23

Review 7.  Novel Mutations of COL4A5 Identified in Chinese Families with X-Linked Alport Syndrome and Literature Review.

Authors:  Wen-Yu Gong; Fan-Na Liu; Liang-Hong Yin; Jun Zhang
Journal:  Biomed Res Int       Date:  2021-03-02       Impact factor: 3.411

8.  Rare diseases, rare presentations: recognizing atypical inherited kidney disease phenotypes in the age of genomics.

Authors:  Elisabet Ars; Roser Torra
Journal:  Clin Kidney J       Date:  2017-07-19

9.  The variable course of women with X-linked Alport Syndrome.

Authors:  Priya Raju; David Cimbaluk; Stephen M Korbet
Journal:  Clin Kidney J       Date:  2013-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.